(Q84922406)
Statements
Transthyretin as a potential CSF biomarker for Alzheimer's disease and dementia with Lewy bodies: effects of treatment with cholinesterase inhibitors (English)
K Schultz
K Nilsson
J E Nielsen
S G Lindquist
L E Hjermind
B B Andersen
A Wallin
C Nilsson
17 November 2009